Vaping devices, long promoted as a safer alternative to traditional tobacco, may carry significant cancer risks according to emerging scientific evidence. A comprehensive review conducted by researchers at the University of Canterbury in New Zealand has concluded that e-cigarettes present an unquantifiable cancer risk, potentially increasing the likelihood of developing cancers of the nose and lung.
Chemical Analysis Reveals Potential Dangers
The research team meticulously analyzed the chemical composition produced when vape liquid is heated and examined how these substances affect the human body. Their findings indicate that while vaping eliminates some of the most harmful components of traditional cigarettes—such as tar and carbon monoxide—it still exposes users to toxic chemicals including formaldehyde, which has established links to cancer development.
Professor Ian Shaw, lead author of the study published in the New Zealand Medical Journal, explained their methodology: "In our paper, we used knowledge of the chemistry of the vaping process to determine the chemical composition of 'vape smoke' and then assessed the carcinogenic risk of each chemical from published animal and other toxicity studies."
The Long-Term Uncertainty
A significant challenge in quantifying vaping's exact cancer risk stems from the extended timeline of cancer development. Cancers typically take fifteen years or more to manifest after exposure to carcinogenic substances, meaning definitive clinical data about vaping's long-term effects may not be available for many years.
"It will take many years to collect clinical data to determine whether vaping causes cancer because it takes at least 15 years for cancers to develop after exposure to cancer-causing chemicals," Professor Shaw noted, highlighting the precautionary nature of their conclusions.
Comparative Risk Assessment
The research provides important context about relative risks. While identifying potential cancer dangers associated with vaping, the scientists consistently emphasized that traditional cigarette smoking remains substantially more hazardous.
The study compared levels of harmful chemicals inhaled from both sources and found cigarettes typically produce much higher amounts of acrolein—a toxic irritant linked to lung and heart damage—and acetaldehyde, another chemical associated with cancer risk. This means smokers are exposed to larger doses of these dangerous substances.
However, formaldehyde—a known cancer-causing chemical—was found at similar levels in both cigarettes and vaping devices, while propionaldehyde also appeared at comparable concentrations. These findings suggest vaping may expose users to lower levels of some toxic chemicals than smoking, but does not eliminate exposure completely.
The Smoking Cessation Dilemma
Despite identifying cancer risks, the researchers acknowledged vaping's role in smoking cessation efforts. "Vaping for smoking cessation is acceptable because this will lower the overall cancer risk," Professor Shaw stated, adding a crucial caveat: "but vaping for its own sake adds to life's cancer risks and is therefore unacceptable."
This nuanced position reflects broader public health debates about harm reduction strategies. The NHS maintains that vaping is "less harmful" than smoking and represents "one of the most effective tools for quitting smoking," while simultaneously cautioning that "vaping is not completely harmless and we don't know yet what the long-term effects may be."
Broader Health Implications
Beyond cancer risks, the research highlights additional health concerns associated with vaping. Studies have shown that people who vape are more likely than non-vapers to develop chronic obstructive pulmonary disease (COPD), a serious lung condition that can ultimately lead to organ failure.
Recent Australian research from Sydney has further strengthened concerns, finding vaping linked to both mouth and lung cancer. After analyzing literature published between 2017 and 2025, Australian researchers concluded that vaping causes tissue damage to the respiratory tract—linked to lung cancer development—and alters the oral microbiome, driving inflammation and increasing oral cancer risk.
Perhaps most alarmingly, the Australian research identified that the risks are highest for dual users—those who both smoke traditional cigarettes and use vapes. This combination, practiced by approximately half of the smoking population, increases lung cancer risk four-fold according to their findings.
Expert Perspectives on the Findings
Public health experts have welcomed the research for bringing scientific clarity to vaping discussions. Andrew Waa, co-director of ASPIRE Aotearoa tobacco control research centre at the University of Otago, noted: "For people who smoke, vapes may help them to quit their nicotine addiction completely or at least switch to vapes. However, simply because vapes are available, a proportion of those who 'switch' might have otherwise quit their addiction. In this case they may be exposed to more harm."
George Laking, associate professor at Te Aka Mātauranga Matepukupu Centre for Cancer Research, University of Auckland, called the report "refreshing" and emphasized the importance of context: "Any work that puts hazards of vaping into context will raise the level of the public conversation. I became interested in vaping because of my work as an oncologist for lung cancer, that remains overwhelmingly caused by smoking cigarettes, that are still many times more dangerous than vaping."
The Scale of Vaping in Britain
These findings arrive at a critical moment for public health policy in the United Kingdom. More than 5.5 million Britons currently use e-cigarettes—a number that now exceeds traditional cigarette smokers among those aged over 16. The Conservative government pledged in 2023 to distribute vapes to more than one million Britons as part of anti-smoking initiatives, reflecting vaping's established role in national health strategy.
As brightly colored, sweetly flavored vaping devices continue to proliferate, this new research underscores the importance of balanced public health messaging—acknowledging vaping's potential as a smoking cessation tool while clearly communicating that it is not risk-free and may carry significant long-term health consequences that are only beginning to be understood.
